Journal of Neuroimmunology
Volume 220, Issue 1 , Pages 17-24 , 30 March 2010

Substance P downregulates expression of the high affinity IgE receptor (FcεRI) by human mast cells

  • Christine McCary

      Affiliations

    • Northwestern University Feinberg School of Medicine, Allergy-Immunology Division, 240 E Huron McGaw #M-327, Chicago, IL 60611, USA
    • ,
  • Brian P. Tancowny

      Affiliations

    • Northwestern University Feinberg School of Medicine, Allergy-Immunology Division, 240 E Huron McGaw #M-327, Chicago, IL 60611, USA
    • ,
  • Adriana Catalli

      Affiliations

    • Institute for Nutrisciences and Health, National Research Council, 550 University Avenue, Charlottetown, PE, Canada C1A 4P3
    • ,
  • Leslie C. Grammer

      Affiliations

    • Northwestern University Feinberg School of Medicine, Allergy-Immunology Division, 240 E Huron McGaw #M-327, Chicago, IL 60611, USA
    • ,
  • Kathleen E. Harris

      Affiliations

    • Northwestern University Feinberg School of Medicine, Allergy-Immunology Division, 240 E Huron McGaw #M-327, Chicago, IL 60611, USA
    • ,
  • Robert P. Schleimer

      Affiliations

    • Northwestern University Feinberg School of Medicine, Allergy-Immunology Division, 240 E Huron McGaw #M-327, Chicago, IL 60611, USA
    • ,
  • Marianna Kulka

      Affiliations

    • Institute for Nutrisciences and Health, National Research Council, 550 University Avenue, Charlottetown, PE, Canada C1A 4P3
    • Corresponding Author InformationCorresponding author. National Research Council Canada, 550 University Avenue, Room 432, Charlottetown, PE C1A 4P3. Tel.: +1 902 367 7550; fax: +1 902 566 7468.

Received 29 July 2009 ,Revised 7 December 2009 ,Accepted 7 December 2009.

References 

  1. Alshurafa HN, Stenton GR, Wallace JL, Hollenberg MD, Befus AD, Vliagoftis H. A protease activated receptor-2 (PAR-2) activating peptide, tc- LI GRL O- NH2, induces protease release from mast cells: role in TNF degradation. BMC Pharmacol. 2004;4:12
  2. Bienenstock J, MacQueen G, Sestini P, Marshall JS, Stead RH, Perdue MH. Mast cell/nerve interactions in vitro and in vivo. Am. Rev. Respir. Dis. 1991;143:S55–S58
  3. Bulut K, Felderbauer P, Deters S, Hoeck K, Schmidt-Choudhury A, Schmidt WE, et al. Sensory neuropeptides and epithelial cell restitution: the relevance of SP-and CGRP-stimul mast cells. Int. J. Colorectal. Dis. 2008;23:535–541
  4. Ercan F, Akici A, Ersoy Y, Hurdag C, Erin N. Inhibition of substance P activity prevents stress-induced bladder damage. Regul. Pept. 2006;133:82–89
  5. Fukuoka Y, Schwartz LB. Human beta-tryptase: detection and characterization of the active monomer and prevention of tetramer reconstitution by protease inhibitors. Biochemistry. 2004;43:10757–10764
  6. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 2005;23:749–786
  7. Groneberg DA, Quarcoo D, Frossard N, Fischer A. Neurogenic mechanisms in bronchial inflammatory diseases. Allergy. 2004;59:1139–1152
  8. He SH, Zheng J. Stimulation of mucin secretion from human bronchial epithelial cells by mast cell chymase. Acta Pharmacol. Sin. 2004;25:827–832
  9. Kang HS, Trzaska KA, Corcoran K, Chang VT, Rameshwar P. Neurokinin receptors: relevance to the emerging immune system. Arch. Immunol Ther. Exp. Warsz. 2004;52:338–347
  10. Kawahira K, Sumiyoshi M, Sakanaka M, Kimura Y. Effects of ginsenoside Rb1 at low doses on histamine, substance P, and monocyte chemoattractant protein 1 in the burn wound areas during the process of acute burn wound repair. J. Ethnopharmacol. 2008;117:278–284
  11. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD. Demonstration that human mast cells arise from a progenit or cell populati on that is CD34 (+), c-kit (+), and expresses aminopeptidase N CD13. Blood. 1999;94:2333–2342
  12. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcgammaRI. Leukoc. Res. 2003;27:677–682
  13. Kuehn HS, Gilfillan AM. G protein-coupled receptors and the modification of FcεRI-mediated mast cell activation. Immunol. Lett. 2007;113:59–69
  14. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology. 2007;
  15. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology. 2008;123:398–410
  16. Lambrecht BN. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir. Res. 2001;2:133–138
  17. Lambrecht BN, Germonpre PR, Everaert EG, Carro-Muino I, De Veerman M, de Felipe C, et al. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur. J Immunol. 1999;29:3815–3825
  18. Langer I, Robberecht P. Molecular mechanisms involved in vasoactive intestinal peptide receptor activation and regulation: current knowledge, similarities to and differences from the A family of G-protein-coupled receptors. Biochem. Soc. Trans. 2007;35:724–728
  19. Langer I, Langlet C, Robberecht P. Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor. J. Mol. Endocrinol. 2005;34:405–414
  20. Montero Mora P, Gonzalez Perez Mdel C, Almeida Arvizu V, Matta Campos JJ. [Autoimmune urticaria. Treatment with methotrexate]. Rev. Alerg. Mex. 2004;51:167–172
  21. Mousli M, Bronner C, Bockaert J, Rouot B, Landry Y. Interaction of substance P, compound 48/80 and mastoparan with the alpha- subunit C-terminus of G protein. Immunol. Lett. 1990;25:355–357
  22. Mousli M, Bronner C, Landry Y, Bockaert J, Rouot B. Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett. 1990;259:260–262
  23. Muramatsu M, Katada J, Hattori M, Hayashi I, Majima M. Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas. Eur. J. Pharmacol. 2000;402:181–191
  24. Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J. Allergy Clin. Immunol. 1992;90:646–652
  25. Nieber K, Baumgarten C, Rathsack R, Furkert J, Laake E, Muller S, et al. Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. Clin. Exp. Allergy. 1993;23:69–71
  26. O'Connor TM, O'Connell J, O' Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J. Cell. Physiol. 2004;201:167–180
  27. Patterson R, Harris KE, Grammer LC, Greenberger PA, Ditto AM, Shaughnessy MA. Potential effect of the administration of substance P and allergen therapy on immunoglobulin E-mediated allergic reactions in human subjects. J. Lab. Clin. Med. 1999;133:189–199
  28. Siebenhaar F, Magerl M, Peters EM, Hendrix S, Metz M, Maurer M. Mast cell-driven skin inflammation is impaired in the absence of sensory nerves. J. Allergy Clin. Immunol. 2008;121:955–961
  29. Tatemoto K, Nozaki Y, Tsuda R, Konno S, Tomura K, Furuno M, et al. Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors. Biochem. Biophys. Res. Commun. 2006;349:1322–1328
  30. Tuluc F, Lai JP, Kilpatrick LE, Evans DL, Douglas SD. Neurokinin 1 receptor isoforms and the control of innate immunity. Trends Immunol. 2009;30:271–276
  31. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034
  32. Weinstock JV, Blum A, Walder J, Walder R. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J. Immunol. 1988;141:961–966
  33. Yamaguchi M, Sayama K, Yano K, Lantz CS, Noben-Trauth N, Ra C, et al. IgE enhances Fcε receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: synergistic effect of I L-4 and IgE on human mast cell Fcepsilon receptor I expression and mediator release. J. Immunol. (Baltimore, Md.: 1950). 1999;162:5455–5465

PII: S0165-5728(09)00489-5

doi: 10.1016/j.jneuroim.2009.12.006

Journal of Neuroimmunology
Volume 220, Issue 1 , Pages 17-24 , 30 March 2010

Article Tools

* Image Usage & Resolution